CSL Behring Announces Grant for EU Advocacy Development
Dear EU Alpha-1 Global Partners:
We are pleased to provide you information regarding CSL Behring’s announcement for Local Empowerment for Advocacy Development (LEAD) Grants available to European Alpha-1 organizations.
Through the LEAD Grant Program, CSL Behring is able to partner with local advocacy organisations whose members use plasma-derived or recombinant therapies to advocate for continued access to health care and their life saving therapies and are based in the EU. The program supports various patient advocacy organisations for grassroots advocacy initiatives focused on developing or improving local standards of care legislation, improving access, and mobilising patient populations.
The EU LEAD Grant proposals is open from 1 November to 20 December 2019, with recipients being announced in January 2020.
For more information about the grant, eligibility requirements, and how to submit a proposal, visit the page: https://www.cslbehring.com/patients/community-engagement/lead-grants
Please contact EUadvocacy@cslbehring.com for any additional questions.